Comparison of Gynecologic History and Laboratory Results in HIV-Positive Women With CD4+ Lymphocyte Counts Between 200 and 500 Cells/μl and Below 100 Cells/μl
Authors:
- Cathie SpinoCSCathie Spino
- Lawrence ZaborskiLZLawrence Zaborski
- David KatzensteinDKDavid Katzenstein
- Scott HammerSHScott Hammer
- Constance BensonCBConstance Benson
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 20 (5) , 455-462
Abstract
To assess rates of sexual activity, contraceptive use, genital infections and dysplasia, and other gynecologic symptoms among well-characterized populations of HIV-seropositive women enrolled in two Adult AIDS Clinical Trials Group (AACTG) randomized studies. Gynecologic data were collected using standardized interview and examination forms from women enrolled in two protocols: ACTG 175, an antiretroviral trial (CD4+ lymphocyte counts 200-500 cells/μl) and ACTG 196, a Mycobacterium avium complex prophylaxis trial (CD4+ counts ≤100 cells/μl). Women enrolled in the two studies were similar in age, race, weight, and history of illicit or injection drug use, but women in ACTG 196 (n = 67) had lower median CD4+ counts (median, 35 cells/μl; range, 0-135 cells/μl versus median, 356 cells/μl; range, 131-620 cells/μl; p < .0005), were less likely to be antiretroviral naive (6% versus 38%; p < .0005), and were more likely to have a Karnofsky score <80 (28% versus 5%; p < .0001) than women in ACTG 175 (n = 185) at baseline. Recent changes in menstrual cycle were not different between groups. Women enrolled in ACTG 196 were less likely to be sexually active (40% versus 61%; p < .005), but both groups reported high levels of contraceptive use. Papanicolaou smear results in ACTG 196 and ACTG 175 respectively, were: normal, 38% and 50%, atypia, 24% and 39%, low-grade squamous intraepithelial lesions (SIL), 27% and 10%, and high-grade SIL, 11% and 0.7% (p < .001). Gynecologic complications are common among HIV-seropositive women with CD4+ lymphocyte counts < 500 cells/μl and are more common and severe among those with more advanced immunosuppression.Keywords
This publication has 23 references indexed in Scilit:
- Immune compromise and prevalence of vulvovaginitis in human immunodeficiency virus—Infected womenObstetrics & Gynecology, 1997
- Vaginal Colonization or Infection with Candida albicans in Human Immunodeficiency Virus-Infected Women During Pregnancy and During the Postpartum PeriodClinical Infectious Diseases, 1997
- Cervical Abnormality and Sexually Transmitted Disease Screening in Human Immunodeficiency Virus-Positive WomenObstetrics & Gynecology, 1997
- Increased Genital Shedding of Herpes Simplex Virus Type 2 in HIV-Seropositive WomenAnnals of Internal Medicine, 1995
- CD4 Lymphocytes in Women with Invasive and Preinvasive Cervical NeoplasiaGynecologic Oncology, 1995
- A population‐based, controlled study of the relation between HIV infection and cervical neoplasiaBJOG: An International Journal of Obstetrics & Gynaecology, 1994
- Clinical Manifestations of Infection with the Human Immunodeficiency Virus in Women in LouisianaClinical Infectious Diseases, 1993
- High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infectionAmerican Journal of Obstetrics and Gynecology, 1991
- The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppressionAmerican Journal of Obstetrics and Gynecology, 1991
- Human immunodeficiency virus infection and cervical neoplasiaGynecologic Oncology, 1990